Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

More News

Cable viewers digest Mueller news through Hannity, Maddow

Mar 23, 2019

NEW YORK — For Sean Hannity, the "witch hunt" was finally over. Rachel Maddow considered it the start of something. The diametrically opposed opinion hosts, who vie for the distinction of the most popular in cable news, were the windows through which many Americans digested Friday's news that special counsel Robert Mueller had concluded a nearly two-year investigation into Russian involvement in the 2016 election. While his report, or even a summary, has not been released, television news still had hours to fill talking about it. Fox News Channel's Hannity, a close Trump ally, focused on reports there will be...

NCAA Latest: Buckeyes, Hokies close 1st round with wins

Mar 23, 2019

The Latest on the first round of the NCAA Tournament (all times Eastern): 12:35 a.m. The first round of the NCAA Tournament is complete. Ohio State beat Iowa State in the Midwest Region, then Virginia Tech held off a comeback attempt by Saint Louis in the East Region to reduce the 68-team field to 32 teams. The 11th-seeded Buckeyes beat the sixth-seeded Cyclones 62-59. And the fourth-seeded Hokies beat the 13th-seeded Billikens 66-52 with point guard Justin Robinson returning from a foot injury sustained in late January. The first tickets to the Sweet 16 go out Saturday. ___ 12:05 a.m....

R Kelly defense emerges, including saying accusers are lying

Mar 23, 2019

CHICAGO — R. Kelly yelled through tears in a recent TV interview before an audience numbering in the millions, saying he's in a fight for his life to disprove sexual abuse charges. That fight will ultimately be waged in court, with the only audience that matters numbering just 12 jurors. While the day lawyers deliver opening statements to jurors inside a Cook County courtroom is still many months or even years away, court filings as well as comments by the R&B star himself and his attorney after charges in February provide clues about an emerging legal strategy. Signs are they...

DJ Khaled inspired by son before hosting Kids' Choice Awards

Mar 23, 2019

LOS ANGELES — In the run-up to the Kids' Choice Awards, host DJ Khaled is feeling plenty of support — from his son. The producer-DJ said his 2-year-old son, Asahd, gets excited just watching his dad in the ads promoting the show on Nickelodeon. "When the commercials come on, my son is like 'Daddy, daddy, daddy!' Because, you know, he watches Nickelodeon. So do I," he said in an interview Thursday. "It's like, the commercial comes on every second," he continued. "And I'm like, man, they've got me looking good out here. My son, to see him smile and say...

A look at Russians who became mixed up in Trump probe

Mar 23, 2019

MOSCOW — An investigation by special counsel Robert Mueller into an elaborate Russian operation that sought to meddle in the 2016 U.S. presidential election and try to help Donald Trump win the White House has cast a spotlight on more than a dozen Russian nationals, including billionaires, an elusive linguist, an ambassador and a pop star. A look at some of the cast of characters: PUTIN'S CHEF Yevgeny Prigozhin, 57, earned the nickname of "Putin's chef" for hosting Russian President Vladimir Putin and his foreign dignitaries at his restaurant and catering important Kremlin events. A former convict, he now runs...

In Celeb Wired, we talk about everything in the entertainment industry from A to Z. We keep our gossip hunters updated with the daily hot news because we have exactly what you’re looking for.

Contact us: sales@celebwired.com

Celebrity Adult Entertainment Animation & Comics Award Shows Beauty Pageants Books & Literature Fashion Shows Movies Music Radio Programs Television Programs Variety Shows Press Releases